Journal
AMERICAN JOURNAL OF TRANSPLANTATION
Volume 14, Issue 11, Pages 2448-2459Publisher
WILEY
DOI: 10.1111/ajt.12939
Keywords
Translational research; science; regenerative medicine; cardiovascular disease; tissue; organ engineering
Categories
Funding
- American Heart Association's Jon Holden DeHaan Cardiac Myogenesis Research Center [AHA09070499N]
- Texas Emerging Technology Fund
- Houston Endowment
Ask authors/readers for more resources
Cardiovascular disease (CVD) is the number one cause of death in the United States. However, few treatments for CVD provide a means to regain full cardiac function with no long-term side effects. Novel tissue-engineered products may provide a way to overcome the limitations of current CVD therapies by replacing injured myocardium with functioning tissue or by inducing more constructive forms of endogenous repair. In this review, we discuss some of the factors that should be considered in the development of tissue-engineered products, and we review the methods currently being investigated to generate more effective heart valves, cardiac patches and whole hearts. This review discusses some of the factors that should be considered in the development of tissue-engineered products, and it describes the methods currently being investigated to generate more effective heart valves, cardiac patches, and whole hearts.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available